These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Splenic T-cell and NK-cell lymphomas: a clinicopathologic and immunophenotypic analysis of 9 cases]. Li Z; Liu WP; Tang Y; Jiang LL; Zhang WY; Bi CF; Li GD Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):217-22. PubMed ID: 17877195 [TBL] [Abstract][Full Text] [Related]
27. Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approach. Thorns C; Bastian B; Pinkel D; Roydasgupta R; Fridlyand J; Merz H; Krokowski M; Bernd HW; Feller AC Genes Chromosomes Cancer; 2007 Jan; 46(1):37-44. PubMed ID: 17044049 [TBL] [Abstract][Full Text] [Related]
28. Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia/lymphoma. Nakagawa M; Nakagawa-Oshiro A; Karnan S; Tagawa H; Utsunomiya A; Nakamura S; Takeuchi I; Ohshima K; Seto M Clin Cancer Res; 2009 Jan; 15(1):30-8. PubMed ID: 19118030 [TBL] [Abstract][Full Text] [Related]
30. [Peripheral T-cell lymphoma: diagnosis and treatment]. Reimer P; Hentrich M Dtsch Med Wochenschr; 2006 Mar; 131(13):685-90. PubMed ID: 16555177 [TBL] [Abstract][Full Text] [Related]
31. Novel targeted therapies in peripheral T cell lymphoma. Jagadeesh D; Smith MR Discov Med; 2013 Jun; 15(85):367-78. PubMed ID: 23819951 [TBL] [Abstract][Full Text] [Related]
32. Controversies in lymphoma: the role of hematopoietic cell transplantation for mantle cell lymphoma and peripheral T cell lymphoma. Dreger P; Laport GG Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):100-7. PubMed ID: 18162229 [TBL] [Abstract][Full Text] [Related]
33. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire. Le Gouill S; Milpied N; Buzyn A; De Latour RP; Vernant JP; Mohty M; Moles MP; Bouabdallah K; Bulabois CE; Dupuis J; Rio B; Gratecos N; Yakoub-Agha I; Attal M; Tournilhac O; Decaudin D; Bourhis JH; Blaise D; Volteau C; Michallet M; J Clin Oncol; 2008 May; 26(14):2264-71. PubMed ID: 18390969 [TBL] [Abstract][Full Text] [Related]
34. Role of single-agent purine analogues in therapy of peripheral T-cell lymphomas. Dearden CE Semin Hematol; 2006 Apr; 43(2 Suppl 2):S22-6. PubMed ID: 16549111 [TBL] [Abstract][Full Text] [Related]
35. Aggressive peripheral T-cell lymphomas (specified and unspecified types). Savage KJ Hematology Am Soc Hematol Educ Program; 2005; ():267-77. PubMed ID: 16304391 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of FoxP3 expression in peripheral T-cell lymphoma. Bonzheim I; Geissinger E; Tinguely M; Roth S; Grieb T; Reimer P; Wilhelm M; Rosenwald A; Müller-Hermelink HK; Rüdiger T Am J Clin Pathol; 2008 Oct; 130(4):613-9. PubMed ID: 18794055 [TBL] [Abstract][Full Text] [Related]
37. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. Reimer P; Rüdiger T; Geissinger E; Weissinger F; Nerl C; Schmitz N; Engert A; Einsele H; Müller-Hermelink HK; Wilhelm M J Clin Oncol; 2009 Jan; 27(1):106-13. PubMed ID: 19029417 [TBL] [Abstract][Full Text] [Related]
38. [Clinical features and treatment outcomes of peripheral T-cell lymphoma, unspecified: a report of 78 cases]. Yu YX; Shi YK; He XH; Zhou LQ; Zhou SY; Dong M; Feng FY; Sun Y Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2714-6. PubMed ID: 18167252 [TBL] [Abstract][Full Text] [Related]